JP7821414B2 - 呼吸器疾患治療のための幹細胞 - Google Patents

呼吸器疾患治療のための幹細胞

Info

Publication number
JP7821414B2
JP7821414B2 JP2022567362A JP2022567362A JP7821414B2 JP 7821414 B2 JP7821414 B2 JP 7821414B2 JP 2022567362 A JP2022567362 A JP 2022567362A JP 2022567362 A JP2022567362 A JP 2022567362A JP 7821414 B2 JP7821414 B2 JP 7821414B2
Authority
JP
Japan
Prior art keywords
mscs
ards
composition
present disclosure
integrin alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022567362A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023524150A (ja
JP2023524150A5 (https=
Inventor
アーケランド，エヴィー ルンドグレン
リンドステット，サンドラ
ウヴブラント，クリスティーナ
モレノ，タニア ラモス
Original Assignee
シンテラ エービー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by シンテラ エービー filed Critical シンテラ エービー
Publication of JP2023524150A publication Critical patent/JP2023524150A/ja
Publication of JP2023524150A5 publication Critical patent/JP2023524150A5/ja
Application granted granted Critical
Publication of JP7821414B2 publication Critical patent/JP7821414B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0662—Stem cells
    • C12N5/0668—Mesenchymal stem cells from other natural sources

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Transplantation (AREA)
JP2022567362A 2020-05-07 2021-05-07 呼吸器疾患治療のための幹細胞 Active JP7821414B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20173592 2020-05-07
EP20173592.5 2020-05-07
PCT/EP2021/062111 WO2021224449A1 (en) 2020-05-07 2021-05-07 Stem cells for treatment of respiratory disorders

Publications (3)

Publication Number Publication Date
JP2023524150A JP2023524150A (ja) 2023-06-08
JP2023524150A5 JP2023524150A5 (https=) 2024-05-14
JP7821414B2 true JP7821414B2 (ja) 2026-02-27

Family

ID=70738255

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022567362A Active JP7821414B2 (ja) 2020-05-07 2021-05-07 呼吸器疾患治療のための幹細胞

Country Status (11)

Country Link
US (1) US20230346843A1 (https=)
EP (1) EP4146234A1 (https=)
JP (1) JP7821414B2 (https=)
KR (1) KR20230008159A (https=)
CN (1) CN116018149A (https=)
AU (1) AU2021266603A1 (https=)
BR (1) BR112022022355A2 (https=)
CA (1) CA3177704A1 (https=)
IL (1) IL297902A (https=)
MX (1) MX2022013939A (https=)
WO (1) WO2021224449A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202103890D0 (en) * 2021-03-19 2021-05-05 Amniotics Ab Stem cells for use in reducing the immune response following organ transplantation

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090232777A1 (en) 2006-03-01 2009-09-17 Evy Lundgren-Akerlund Expansion and Differentiation of Mesenchymal Stem Cells
WO2018159432A1 (ja) 2017-03-03 2018-09-07 ロート製薬株式会社 間葉系幹細胞及び医薬組成物
JP2020505916A (ja) 2017-01-27 2020-02-27 シンテラ エービー 骨および軟骨の損傷または疾患の予防および治療

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110177560A (zh) * 2016-12-28 2019-08-27 智再如股份有限公司 活体组织损伤的修复剂以及该修复剂的制造方法
CN116590227A (zh) * 2017-03-03 2023-08-15 日本乐敦制药株式会社 间充质干细胞和肝疾病治疗剂

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090232777A1 (en) 2006-03-01 2009-09-17 Evy Lundgren-Akerlund Expansion and Differentiation of Mesenchymal Stem Cells
JP2020505916A (ja) 2017-01-27 2020-02-27 シンテラ エービー 骨および軟骨の損傷または疾患の予防および治療
WO2018159432A1 (ja) 2017-03-03 2018-09-07 ロート製薬株式会社 間葉系幹細胞及び医薬組成物

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Cell Biology and Toxicology，2019年，Vol. 36，No. 1，pp. 83-102，DOI: 10.1007/s10565-019-09493-5
Stem Cells International，2019年，Vol. 2019, Article ID 4236973，pp. 1-14，DOI: 10.1155/2019/4236973
Stem Cells International，2019年，Vol. 2019，Article ID: 5432134, pp. 1-12，DOI: 10.1155/2019/5432134

Also Published As

Publication number Publication date
CN116018149A (zh) 2023-04-25
BR112022022355A2 (pt) 2022-12-13
JP2023524150A (ja) 2023-06-08
MX2022013939A (es) 2023-02-09
CA3177704A1 (en) 2021-11-11
US20230346843A1 (en) 2023-11-02
EP4146234A1 (en) 2023-03-15
KR20230008159A (ko) 2023-01-13
WO2021224449A1 (en) 2021-11-11
AU2021266603A1 (en) 2022-12-08
IL297902A (en) 2023-01-01

Similar Documents

Publication Publication Date Title
AU2018316603B2 (en) Purified mesenchymal stem cell exosomes and uses thereof
JP7691488B2 (ja) 肺疾患を治療するための方法及び組成物
Chou et al. Human mesenchymal stem cells attenuate experimental bronchopulmonary dysplasia induced by perinatal inflammation and hyperoxia
US10723997B2 (en) Composition for treating chronic pulmonary disease, comprising exosome derived from thrombin-treated stem cell
US10272109B2 (en) Organs for transplantation
KR102464099B1 (ko) 다능성 간세포에 의한 허혈재관류 폐장애의 경감 및 치료
JP7821414B2 (ja) 呼吸器疾患治療のための幹細胞
Siavashi et al. The improvement of respiratory performance after phototherapy‐induced EPC mobilization in preterm infants with RDS
WO2014089397A1 (en) Compositions and methods of treating and preventing pulmonary fibrosis
US20200054684A1 (en) Non-mesenchymal human lung stem cells and methods of their use for treating respiratory diseases
US20230338432A1 (en) Methods and compositions for treating viral infections and sequelae thereof
Tran et al. The synergistic effects of mechanical ventilation and intrauterine inflammation on cerebral inflammation in preterm fetal sheep
Wu et al. Wnt3a Enhances Mesenchymal Stem Cell Engraftment and Differentiation in a Chronic Obstructive Pulmonary Disease Rat Model
Deguise et al. The Role of Mesenchymal Stromal Cells in the Treatment of Bronchopulmonary Dysplasia: A Multi-Prong Approach for a Heterogeneous Disease
WO2025259857A1 (en) Human trophoblast stem cell secretomes, exosomes, and uses thereof
Papagianis Anti-inflammatory therapies for bronchopulmonary dysplasia
Moawed et al. Assessment of cord blood vascular endothelial growth factor levels and circulating CD34+ cells in preterm infants with respiratory distress syndrome
Curley Investigation of the mechanisms of repair following Ventilator Induced Lung Injury and the potential for Mesenchymal Stem Cells to enhance the repair process
HK1214130B (en) Improving organs for transplantation

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240430

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240430

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250520

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250819

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20251017

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20251020

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20260113

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20260203

R150 Certificate of patent or registration of utility model

Ref document number: 7821414

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150